Copyright
©The Author(s) 2017.
World J Gastroenterol. Oct 28, 2017; 23(40): 7303-7309
Published online Oct 28, 2017. doi: 10.3748/wjg.v23.i40.7303
Published online Oct 28, 2017. doi: 10.3748/wjg.v23.i40.7303
Table 5 Comparison of prediction performance of the model for end-stage liver disease and the modified model
Groups | Non-survival | Survival | χ2, P value | |
MELD | MELD < 25 | 16 | 83 | 56.98, < 0.001 |
MELD≥ 25 | 90 | 47 | ||
MELD-LAC | MELD-LAC < -0.4741 | 13 | 100 | 107.35, < 0.001 |
MELD-LAC ≥ -0.4741 | 97 | 26 |
- Citation: Chen W, You J, Chen J, Zheng Q, Jiang JJ, Zhu YY. Modified model for end-stage liver disease improves short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol 2017; 23(40): 7303-7309
- URL: https://www.wjgnet.com/1007-9327/full/v23/i40/7303.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i40.7303